Interpharm Holdings, Inc.

IPAH · OTC
Analyze with AI
12/31/2007
9/30/2007
6/30/2007
3/31/2007
Market Cap$287$847$843$1,059
- Cash$41$68$72$184
+ Debt$38,471$31,788$26,545$16,675
Enterprise Value$38,717$32,567$27,316$17,550
Revenue$16,214$17,715$15,372$19,910
% Growth-8.5%15.2%-22.8%
Gross Profit$2,269$1,076$2,280$6,375
% Margin14%6.1%14.8%32%
EBITDA-$2,974-$5,220-$6,487-$1,681
% Margin-18.3%-29.5%-42.2%-8.4%
Net Income-$10,897-$6,896-$9,711-$1,852
% Margin-67.2%-38.9%-63.2%-9.3%
EPS Diluted-0.21-0.1-0.153-0.04
% Growth-110%34.8%-283.2%
Operating Cash Flow-$6,354-$3,481-$7,255-$4,655
Capital Expenditures-$551-$1,507-$3,011-$2,792
Free Cash Flow-$6,905-$4,988-$10,266-$7,447
Interpharm Holdings, Inc. (IPAH) Financial Statements & Key Stats | AlphaPilot